Translate Bio
Lexington
About Translate Bio
Translate Bio is a biotechnology company that in biotechnology, RNA therapeutics, and rare diseases. Translate Bio is a therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $442.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2020)
- Ticker: nasdaq:TBIO
- Website: translate.bio
- Phone: (617) 945-7361
Industries & Categories
Biotechnology, Genetics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/translate-bio-108973 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.